Lessons From Lockdown: Hepatitis Delta Elimination Strategies in the COVID-19 Era
In this engaging dialogue, 2 expert hepatologists discuss strategies to maintain and improve screening and testing for hepatitis delta virus in the COVID-19 era.
Decera Clinical Education Infectious Disease Podcast · Robert G. Gish MD FAASLD AGAF FAST, Pietro Lampertico MD PhD
Audio is streamed directly from the publisher (afp-928689-injected.calisto.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In this episode, Robert G. Gish, MD, and Pietro Lampertico, MD, PhD, share lessons learned in the care of patients coinfected with hepatitis B virus and hepatitis delta virus (HDV), including:
- Burden of HDV infection
- Chronic HDV infection and comorbidities
- Impact of COVID-19 on care of patients with chronic hepatitis B
- Screening for HDV and which assays to use
- Screening for viral hepatitis at a COVID-19 vaccination site
Presenters:
Robert G. Gish, MD, FAASLD, AGAF, FAST
Professor of Medicine
Loma Linda University
Loma Linda, California
Clinical Professor
University of Nevada Reno School of Medicine
Reno, Nevada
University of California Skaggs School of Pharmacy and Pharmaceutical Sciences
San Diego, California
Medical Director
Hepatitis B Foundation
Washington, DC
Pietro Lampertico, MD, PhD
Professor of Gastroenterology
Director, Division of Gastroenterology and Hepatology
IRCCS Ca Granda Policlinico Hospital
University of Milan
Milan, Italy
Follow along with the slides at:
https://bit.ly/3HQ6dZ5
Link to full program:
https://bit.ly/3Bgyd5I
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.